The prognostic value of serum albumin levels on admission in patients with acute ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention

Coronary Artery Disease

Volumn 24, Issue 2, 2013, Pages 88-94

  Oduncu, Vecih ^a   Erkol, Ayhan ^b   Karabay, Can Y ^c   Kurt, Mustafa ^d   Akgün, Taylan ^c   Bulut, Mustafa ^c   Pala, Selçuk ^c   Kirma, Cevat ^c  

^a Medical Park Fatih Hospital   (Turkey)

^b Kocaeli Derince Education and Research Hospital   (Turkey)

^c KOSUYOLU HEART AND RESEARCH HOSPITAL   (Turkey)

^d MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

albumin; heart failure; myocardial infarction; primary angioplasty; prognosis

Indexed keywords

ACETYLSALICYLIC ACID; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CLOPIDOGREL; CONTRAST MEDIUM; DIURETIC AGENT; ENOXAPARIN; HEMOGLOBIN; HEPARIN; INOTROPIC AGENT; SERUM ALBUMIN; TIROFIBAN; TROPONIN I;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; BALLOON DILATATION; CARDIAC PATIENT; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTRAST INDUCED NEPHROPATHY; CORONARY STENT; DIURETIC THERAPY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPOALBUMINEMIA; INCIDENCE; LEUKOCYTE COUNT; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

CARDIOTONIC AGENTS; CHOLESTEROL; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; DIURETICS; DRUG UTILIZATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART FAILURE; HEMOGLOBINS; HOSPITAL MORTALITY; HUMANS; HYPOALBUMINEMIA; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT ADMISSION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECURRENCE; RETROSPECTIVE STUDIES; SERUM ALBUMIN; STROKE; STROKE VOLUME;

EID: 84873407790     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32835c46fd     Document Type: Article

References (32)

1. Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC. Albumin levels predict survival in patients with systolic heart failure. Am Heart J 2008; 155:883-889
2. Dziedzic T, Slowik A, Szczudlik A. Serum albumin level as a predictor of ischemic stroke outcome. Stroke 2004; 35:156-158
3. Lowrie EG, Lew NL. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15:458-482 (Pubitemid 20174016)
4. Wallace SM,Walton BI, Kharbanda RK, Hardy R, Wilson AP, Swanton RH. Mortality from infective endocarditis: Clinical predictors of outcome. Heart 2002; 88:53-60 (Pubitemid 34665003)
5. Nelson JJ, Liao D, Sharrett A, Folsom AR, Chambless LE, Shahar E, et al. Serum albumin level as a predictor of incident coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 2000; 151:468-477 (Pubitemid 30471021)
6. Djoussé L, Rothman KJ, Cupples LA, Levy D, Ellison RC. Effect of serum albumin and bilirubin on the risk of myocardial infarction (the Framingham Offspring Study). Am J Cardiol 2003; 91:485-488 (Pubitemid 36183578)
7. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470 (Pubitemid 29135798)
8. Rao AK, Pratt C, Berke A, Jaffe A, Ockene I, Schreiber TL, et al. Thrombolysis in myocardial infarction (TIMI) Trial-phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 1988; 11:1-11 (Pubitemid 18029027)
9. Don BR, Kaysen GA. Serum albumin: Relationship to inflammation and nutrition. Semin Dial 2004; 17:432-437 (Pubitemid 40110428)
10. Chojkier M. Inhibition of albumin synthesis in chronic diseases: Molecular mechanisms. J Clin Gastroenterol 2005; 39 (Suppl 2):143-146
11. Kaysen GA, Stevenson FT, Depner TA. Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 1997; 29:658-668 (Pubitemid 27209666)
12. Lyons O,Whelan B, Bennett K, O'Riordan D, Silke B. Serum albumin as an outcome predictor in hospital emergency medical admissions. Eur J Intern Med 2010; 21:17-20
13. Phillips A, Shaper AG,Whincup PH. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet 1989; 2:1434-1436 (Pubitemid 20012066)
14. Ramadori G, VanDamme J, Rieder H, Meyer KH. Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Eur J Immunol 1988; 18:12544-12564
15. Danesh J, Muir J,Wong YK,Ward M, Gallimore JR, Pepys MB. Risk factors for coronary heart disease and acute-phase proteins. A populationbased study. Eur Heart J 1999; 20:954-959 (Pubitemid 29281442)
16. Kaysen GA, Dubin JA, Muller HG, Rosales LM, Levin NW. and the HEMO study group. The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. Kidney Int 2000; 58: 346-352 (Pubitemid 30429881)
17. Kinjo K, Sato H, Ohnishi Y, Hishida E, Nakatani D, Mizuno H, et al. Osaka acute coronary insufficiency study (OACIS) group. Impact of high-sensitivity C-reactive protein on predicting long-term mortality of acute myocardial infarction. Am J Cardiol 2003; 91:931-935 (Pubitemid 36398523)
18. Clarke R, Emberson JR, Breeze E, Casas JP, Parish S, Hingorani AD, et al. Biomarkers of inflammation predict both vascular and non-vascular mortality in older men. Eur Heart J 2008; 29:800-809 (Pubitemid 351431029)
19. Narang R, Ridout D, Nonis C, Kooner JS. Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease. Int J Cardiol 1997; 60:73-79 (Pubitemid 27288259)
20. Rezkalla SH, Kloner RA. Coronary no-reflow phenomenon: From the experimental laboratory to the cardiac catheterization laboratory. Catheter Cardiovasc Interv 2008; 72:950-957
21. Arques S, Ambrosi P. Human serum albumin in the clinical syndrome of heart failure. J Card Fail 2011; 17:451-458
22. Lapenna D, Ciofani G, Ucchino S, Pierdomenico SD, Cuccurullo C, Giamberardino MA, et al. Serum albumin and biomolecular oxidative damage of human atherosclerotic plaques. Clin Biochem 2010; 43: 1458-1460
23. ZhangWJ, Frei B. Albumin selectively inhibits TNF alpha-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc Res 2002; 55:820-829
24. Prajapati KD, Sharma SS, Roy N. Current perspectives on potential role of albumin in neuroprotection. Rev Neurosci 2011; 22:355-363
25. Zoellner H, Höfler M, Beckmann R, Hufnagl P, Vanyek E, Bielek E, et al. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Sci 1996; 109:2571-2580 (Pubitemid 26377532)
26. Halliwell B. Albumin: An important extracellular antioxidant? Biochem Pharmacol 1988; 37:569-571
27. Ishizaka N, Ishizaka Y, Nagai R, Toda EI, Hashimoto H, Yamakado M. Association between serum albumin, carotid atherosclerosis, and metabolic syndrome in Japanese individuals. Atherosclerosis 2007; 193:373-379 (Pubitemid 47058100)
28. Gillum RF, Ingram DD, Makuc DM. Relation between serum albumin concentration and stroke incidence and death: The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1994; 140:876-888 (Pubitemid 24355551)
29. Gopal DM, Kalogeropoulos AP, Georgiopoulou VV, Tang WW, Methvin A, Smith AL, et al. for the Health ABC Study. Serum albumin concentration and heart failure risk: The Health, Aging, and Body composition Study. Am Heart J 2010; 160:279-285
30. Gaar KA Jr, Taylor AE, Owens LJ, Guyton AC. Effect of capillary pressure and plasma protein on development of pulmonary edema. Am J Physiol 1967; 213:79-82
31. Anand IS, Latini R, Florea VG, Kuskowski MA, Rector T, Masson S, et al. Val- HeFT Investigators. C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation 2005; 112:1428-1434 (Pubitemid 41291768)
32. Miyamoto M, McClure DE, Schertel ER, Andrews PJ, Jones GA, Pratt JW, et al. Effects of hypoproteinemia-induced myocardial edema on left ventricular function. Am J Physiol 1998; 274:937-944.